To best understand the side effects of CBD and its reactions to pharmaceutical drugs, its first important to understand how the human body reacts to and processes cannabidiol. From a neurological perspective, CBD interacts very closely with the endocannabinoid system (also known as the ECS). Generally, the ECS can be described as the system in all mammals that is used to adapt to changes in our environment, and it is responsible for many of our day-to-day bodily processes.
“Acute CBD administration by the oral, inhalatory or intravenous route did not induce any significant toxic effect in humans. In addition, chronic administration of CBD for 30 days to healthy volunteers, at daily doses ranging from 10 to 400 mg, failed to induce any significant alteration in neurological, psychiatric or clinical exams. Finally, in patients suffering from Huntington’s disease, daily doses of CBD (700 mg) for 6 weeks did not induce any toxicity. Therefore, confirming results from animal studies, the available clinical data suggest that CBD can be safely administered over a wide dose range.“
Each bottle contains 200 drops, and Provacan recently increased the size of the larger option by 20%. If you choose the 1200mg option, you receive 6mg of CBD per drop in the 10ml bottle. The company has also boosted the terpene profile of its oil along with levels of additional cannabinoids, including CBG, CBC, THCa, and CBDv – all non-psychoactive compounds that do not produce a high.